 |
For more information, please contact your Hospira Representative, or call 1-866-488-6088. |
| www.hospira.ca | |
| Website Privacy Policy Legal Notices | Hospira Healthcare Corporation Montréal (Québec) H4M 2X6 |
 |
 |
|
|
|
|
Learn more about potential concerns raised by DEHP, Health Canada recommendations, and our initiative to remove DEHP from all Hospira IV gravity and pump administration sets. |
What is DEHP?
| > | Di(2-ethylhexyl)phthalate (DEHP) is a plasticizer or softener used to increase the flexibility of polyvinyl chloride (PVC) |
> | DEHP can potentially leach from PVC into fluids that come into contact with it* |
> |
Medical devices made from PVC, such as intravenous tubing, typically contain 20-40% DEHP |
> |
There is concern about DEHP exposure among certain patient groups |
*To date, there have been no cases of toxicities/adverse events directly attributed to DEHP, but Hospira is taking the lead in developing non-DEHP alternatives |
|||
How Hospira is taking the lead on DEHP
| Hospira is the only company in Canada addressing potential safety concerns about DEHP
by actively converting ALL IV administration sets to non-DEHP |
|||||
| > | Hospira is committed to enhancing patient safety |
> | Many Hospira products are already non-DEHP |
> | Upgrading to non-DEHP products will be completed at no additional charge to our customers |
> |
All non-DEHP alternatives from Hospira have comparable configurations to the products they replace |
> |
The transition to non-DEHP IV administration sets is ongoing; more information updates coming soon |
||
| Our commitment to safety: Helping you limit patient exposure to DEHP |
A greener alternative:
Reducing the release of DEHP into the environment |
| Efficient solutions: Converting all our IV administration sets will help you eliminate unnecessary duplication in your hospital inventory |
A successful transition: Hospira will be right behind you to ensure a successful transition to non-DEHP alternatives |